SOLARIS VACCINES
Solaris Vaccines is a biotechnology company that develops therapeutic vaccines for infectious diseases. The Solaris SolaVAX method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new approach for creating vaccines against pathogens such as viruses, bacteria, and parasites. Solaris Vaccines was formed in 2021 to address many of the challenges of creating vaccines in response to emerging threats to global human health.
SOLARIS VACCINES
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2021-01-01
Address:
Fort Collins, Colorado, United States
Country:
United States
Website Url:
http://www.solarisvax.com
Status:
Active
Total Funding:
500 K USD
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Drift Biotechnologies
Drift Biotechnologies develops bioinformatics software for infectious disease genetic sequencing.
Flightpath Biosciences
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
Lifemax
Lifemax is a biotechnology company that develops therapeutics for various medical sectors.
Neurome
Neurome, Inc. is a discovery stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Pana Bio
Pana Bio is a biotechnology company that delivers therapeutic molecules in vivo.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Official Site Inspections
http://www.solarisvax.com Semrush global rank: 5.41 M Semrush visits lastest month: 1.56 K
- Host name: jib.gcmcomputers.com
- IP address: 148.59.95.12
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Solaris Vaccines"
Solaris Vaccines - Crunchbase Company Profile
Solaris Vaccines is a biotechnology company that develops therapeutic vaccines for infectious diseases. The Solaris SolaVAX method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new …See details»
Solaris Vaccines - LinkedIn
Solaris Vaccines | 283 followers on LinkedIn. Rapid, Safe and Effective Vaccines for Global Health | Addressing the significant threat to global health posed by current and future …See details»
Solaris Vaccines - Overview, News & Similar companies - ZoomInfo
Apr 18, 2023 www.solarisvax.com. Revenue $6.3 Million. Industry Business Services General Business Services . Recent News & Media. Solaris Vaccines Awarded Funding from NIH to …See details»
SOLARIS VACCINES, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SOLARIS VACCINES, INC. of Fort Collins, CO. Get the latest business insights from Dun & Bradstreet.See details»
Solaris Vaccines - PitchBook
Solaris Vaccines General Information Description. Developer of vaccine development platform intended to offer treatment against viruses. The company uses photochemical …See details»
Solaris Vaccines - VentureRadar
Website: https://solarisvax.com/ Solaris Vaccines, Inc. was formed 2021 to address many of the challenges of creating vaccines in response to emerging threats to ...See details»
From the Corner Office: Michael Artinger, PhD – CEO of ... - LinkedIn
Jul 28, 2023 Please feel free to contact me at [email protected] if you are interested in learning more about this important work. Help improve contributions.See details»
Solaris Vaccines Formed to Develop and Commercialize a Rapid, …
Sep 20, 2021 VIC Technology Venture Development, LLC (VIC), announced today the formation of Colorado-based Solaris Vaccines, Inc., to advance a new vaccine development platform …See details»
Solaris Vaccines Awarded Funding from NIH to Develop Novel
Jun 21, 2023 This NIAID SBIR will evaluate an innovative approach for producing superior vaccines more quickly and cost-effectively. FORT COLLINS, Colo. (PRWEB) June 21, 2023 …See details»
Solaris Vaccines on LinkedIn: Solaris Vaccines Awarded Funding …
Solaris Vaccines secures a National Institute of Allergy and Infectious Diseases (NIAID) SBIR grant to develop an improved flu vaccine, aiming to produce more…See details»
Research Scientist - Salary.com
Apply for the Job in Research Scientist at Fort Collins, CO. View the job description, responsibilities and qualifications for this position. Research salary, company info, career …See details»
Solaris Vaccines - Company Profile - Tracxn
Sep 14, 2024 Solaris Vaccines - Developer of therapeutic vaccines for infectious diseases. Raised funding over 2 rounds from 2 investors. Solaris Vaccines has 261 competitors.See details»
Canada to donate almost 18 million surplus AstraZeneca doses to …
Jul 13, 2021 Canada is donating 17.7 million doses of the AstraZeneca coronavirus vaccine to help inoculate people in low- and middle-income countries, federal ministers announced Monday.See details»
COVAX: ensuring global access to COVID-19 vaccines
UNICEF is leading global efforts in the world’s largest and fastest ever procurement and supply of vaccines. We are working to ensure all countries that are part of the COVID-19 Vaccine Global …See details»
What is COVAX and why is Canada getting backlash for receiving …
Feb 5, 2021 COVAX is a global vaccine-sharing initiative jointly co-ordinated by the World Health Organization, the Coalition for Epidemic Preparedness Innovations, and Gavi, The Vaccine …See details»
Research Scientist - LinkedIn
Position: Research Scientist. Company: Solaris Vaccines. Location: Fort Collins, CO, USA. Type: Part-Time 50% (20 hours per week) Salary: $65,000-$85,000 (full-time base salary), …See details»
Covax explained: The plan to vaccinate the world - BBC
A global plan called Covax is trying to share vaccines fairly among all nations - but can it succeed?See details»
Canada offering help as COVAX vaccine alliance pleads for more …
Feb 1, 2022 Seth Berkley, the CEO of the Gavi vaccine alliance helping run COVAX, is hopeful that bigger vaccine supplies in 2022 will help meet the World Health Organization target to get …See details»
Home | Immunize.org
WHO Position papers on vaccines and other vaccine-related resources from the World Health Organization; News & Updates. IZ Express Newsletter Weekly digest of important …See details»
Coronavirus: Ottawa-designed vaccine system gains praise in N.S ...
May 6, 2021 An Ottawa-designed immunization booking system is gaining praise in Nova Scotia for its simplicity and effectiveness compared to the COVID-19 vaccine rollout in other provinces.See details»